Philadelphia, PA, United States of America

Xiaochuan Shan

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Janssen Biotech, Inc.. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaochuan Shan. Retrieved from https://idiyas.com/inventor/xiaochuan-shan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Xiaochuan Shan in Cancer Treatment

Introduction

Xiaochuan Shan is a notable inventor based in Philadelphia, PA, who has made significant contributions to the field of cancer treatment. He holds 2 patents that focus on innovative therapies for acute myeloid leukemia. His work is instrumental in advancing medical science and improving patient outcomes.

Latest Patents

Xiaochuan Shan's latest patents include methods of treatment for acute myeloid leukemia using anti-CD38 antibodies. These inventions provide new avenues for combating this aggressive form of cancer, showcasing his commitment to enhancing therapeutic options for patients.

Career Highlights

Xiaochuan Shan is currently associated with Janssen Biotech, Inc., where he continues to develop groundbreaking treatments. His expertise and dedication to research have positioned him as a key figure in the pharmaceutical industry.

Collaborations

Some of his notable coworkers include Parul Doshi and Gwenn Danet-Desnoyers, who collaborate with him on various projects aimed at improving cancer therapies.

Conclusion

Xiaochuan Shan's contributions to the field of cancer treatment through his patents and work at Janssen Biotech, Inc. highlight his role as an influential inventor in the medical community. His innovations are paving the way for more effective treatments for acute myeloid leukemia.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…